0001372514-24-000093.txt : 20240703 0001372514-24-000093.hdr.sgml : 20240703 20240703151609 ACCESSION NUMBER: 0001372514-24-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stengone Carmine N. CENTRAL INDEX KEY: 0001861519 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 241099807 MAIL ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 332 ENCINITAS BOULEVARD STREET 2: SUITE 102 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: 781-788-8869 MAIL ADDRESS: STREET 1: 332 ENCINITAS BOULEVARD STREET 2: SUITE 102 CITY: ENCINITAS STATE: CA ZIP: 92024 FORMER COMPANY: FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060811 4 1 wk-form4_1720034163.xml FORM 4 X0508 4 2024-07-01 0 0001372514 KIORA PHARMACEUTICALS INC KPRX 0001861519 Stengone Carmine N. C/O KIORA PHARMACEUTICALS, INC. 332 ENCINITAS BLVD., SUITE 102 ENCINITAS CA 92024 1 0 0 0 0 Stock Option (right to buy) 4.35 2024-07-01 4 A 0 1778 0 A 2025-07-01 2034-07-01 Common Stock 1778 1778 D The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025. /s/ Melissa Tosca, Attorney-in-Fact 2024-07-03